Rh-EPO

recombinant human erythropoietin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rh-EPO, covering 2021-08-11 to 2021-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma [Phase 3]